Jaguar Health, Inc. — Form 8-K
Filed July 1, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
On June 25, 2026, Jaguar Health completed conversion of all outstanding Series O Preferred Stock into 4,857,211 shares of Common Stock at a conversion ratio of 3.209 shares per preferred share. The company also issued warrant conversion shares; warrant holders can now exercise for up to 839,000 common shares (comprising 68,593 original warrant shares and 770,407 conversion shares).
Why this rating
Massive share dilution (4.86M new shares) on a $3.8M market-cap micro-cap company is material. Conversion was pre-announced and non-cash; changes capital structure significantly but is mechanical conversion, not new funding or loss.
See more from July 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.